Vanguard Group’s Vascular Solutions Inc VASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-853,962
| Closed | -$47.9M | – | 4107 |
|
|
2016
Q4 | $47.9M | Buy |
853,962
+39,668
| +5% | +$2.02M | ﹤0.01% | 2003 |
|
|
2016
Q3 | $39.3M | Buy |
814,294
+24,287
| +3% | +$1.13M | ﹤0.01% | 2041 |
|
|
2016
Q2 | $32.9M | Buy |
790,007
+39,808
| +5% | +$1.48M | ﹤0.01% | 2092 |
|
|
2016
Q1 | $24.4M | Buy |
750,199
+48,414
| +7% | +$1.4M | ﹤0.01% | 2207 |
|
|
2015
Q4 | $24.1M | Buy |
701,785
+38,547
| +6% | +$1.31M | ﹤0.01% | 2221 |
|
|
2015
Q3 | $21.5M | Buy |
663,238
+45,158
| +7% | +$1.62M | ﹤0.01% | 2262 |
|
|
2015
Q2 | $21.5M | Buy |
618,080
+59,781
| +11% | +$1.95M | ﹤0.01% | 2321 |
|
|
2015
Q1 | $16.9M | Buy |
558,299
+74,723
| +15% | +$2.15M | ﹤0.01% | 2396 |
|
|
2014
Q4 | $13.1M | Sell |
483,576
-21,493
| -4% | -$584K | ﹤0.01% | 2419 |
|
|
2014
Q3 | $12.5M | Buy |
505,069
+82,197
| +19% | +$1.95M | ﹤0.01% | 2396 |
|
|
2014
Q2 | $9.38M | Buy |
422,872
+25,141
| +6% | +$550K | ﹤0.01% | 2530 |
|
|
2014
Q1 | $10.4M | Buy |
397,731
+10,292
| +3% | +$256K | ﹤0.01% | 2471 |
|
|
2013
Q4 | $8.97M | Buy |
387,439
+17,980
| +5% | +$352K | ﹤0.01% | 2515 |
|
|
2013
Q3 | $6.21M | Buy |
369,459
+288
| +0.1% | +$4.66K | ﹤0.01% | 2626 |
|
|
2013
Q2 | $5.43M | Buy |
+369,171
| New | +$5.81M | ﹤0.01% | 2617 |
|
Other funds holding VASC
Vanguard Group's VASC Position: Q1 2017 in Review
Vanguard Group sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 853,962 shares — an estimated $47.9M sold.
Vanguard Group first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $47.9M in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.
- Vanguard Group reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
- Vanguard Group sold 853,962 Vascular Solutions Inc shares in Q1 2017, an estimated $47.9M.
- Vanguard Group first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 15 quarters.
- Vanguard Group's Vascular Solutions Inc position peaked at $47.9M in Q4 2016.
- 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.
Based on Vanguard Group's 13F filing for Q1 2017, filed 12 May 2017.